Boston Trust Walden’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $43.9M | Buy |
585,148
+83,263
| +17% | +$5.35M | 0.33% | 106 |
|
|
2026
Q1 | $28.3M | Sell |
501,885
-78,765
| -14% | -$5.13M | 0.23% | 151 |
|
|
2025
Q4 | $46.5M | Sell |
580,650
-376,040
| -39% | -$25.3M | 0.35% | 110 |
|
|
2025
Q3 | $46.6M | Sell |
956,690
-133,250
| -12% | -$8.25M | 0.34% | 119 |
|
|
2025
Q2 | $81.3M | Sell |
1,089,940
-28,391
| -3% | -$1.88M | 0.58% | 55 |
|
|
2025
Q1 | $71.1M | Buy |
1,118,331
+202,609
| +22% | +$13.8M | 0.52% | 67 |
|
|
2024
Q4 | $71.5M | Buy |
915,722
+106,114
| +13% | +$8.52M | 0.5% | 67 |
|
|
2024
Q3 | $65.1M | Buy |
809,608
+98,019
| +14% | +$7.92M | 0.45% | 83 |
|
|
2024
Q2 | $58.9M | Sell |
711,589
-276
| -0% | -$24.3K | 0.44% | 85 |
|
|
2024
Q1 | $60.8M | Sell |
711,865
-4,601
| -0.6% | -$361K | 0.43% | 80 |
|
|
2023
Q4 | $61.3M | Sell |
716,466
-4,063
| -0.6% | -$351K | 0.46% | 75 |
|
|
2023
Q3 | $64.5M | Buy |
720,529
+51,669
| +8% | +$4.61M | 0.54% | 60 |
|
|
2023
Q2 | $56.9M | Buy |
668,860
+19,953
| +3% | +$1.69M | 0.47% | 71 |
|
|
2023
Q1 | $53.7M | Buy |
648,907
+23,651
| +4% | +$1.91M | 0.46% | 72 |
|
|
2022
Q4 | $49.2M | Sell |
625,256
-3,569
| -0.6% | -$287K | 0.43% | 78 |
|
|
2022
Q3 | $46.6M | Buy |
628,825
+20,849
| +3% | +$1.5M | 0.46% | 71 |
|
|
2022
Q2 | $39.6M | Sell |
607,976
-222,914
| -27% | -$13.2M | 0.37% | 95 |
|
|
2022
Q1 | $52.5M | Buy |
830,890
+189,457
| +30% | +$10.3M | 0.43% | 83 |
|
|
2021
Q4 | $34M | Buy |
641,433
+181,560
| +39% | +$11.1M | 0.27% | 127 |
|
|
2021
Q3 | $32.5M | Buy |
459,873
+240,419
| +110% | +$15.2M | 0.29% | 127 |
|
|
2021
Q2 | $14.6M | Sell |
219,454
-9,601
| -4% | -$679K | 0.13% | 195 |
|
|
2021
Q1 | $25.4M | Sell |
229,055
-26,117
| -10% | -$3.23M | 0.25% | 146 |
|
|
2020
Q4 | $30.3M | Buy |
255,172
+408
| +0.2% | +$43.9K | 0.32% | 108 |
|
|
2020
Q3 | $22.2M | Buy |
254,764
+54,748
| +27% | +$4.78M | 0.28% | 125 |
|
|
2020
Q2 | $17.9M | Buy |
200,016
+25,014
| +14% | +$2.53M | 0.24% | 136 |
|
|
2020
Q1 | $17.4M | Buy |
175,002
+53,517
| +44% | +$5.8M | 0.28% | 116 |
|
|
2019
Q4 | $14M | Buy |
121,485
+2,546
| +2% | +$308K | 0.16% | 178 |
|
|
2019
Q3 | $15M | Buy |
118,939
+920
| +0.8% | +$117K | 0.19% | 163 |
|
|
2019
Q2 | $14.2M | Sell |
118,019
-1,573
| -1% | -$155K | 0.18% | 162 |
|
|
2019
Q1 | $10.5M | Sell |
119,592
-32,814
| -22% | -$2.98M | 0.14% | 186 |
|
|
2018
Q4 | $15.2M | Sell |
152,406
-67,955
| -31% | -$7.14M | 0.24% | 119 |
|
|
2018
Q3 | $25.2M | Sell |
220,361
-12,383
| -5% | -$1.28M | 0.35% | 90 |
|
|
2018
Q2 | $20.9M | Sell |
232,744
-33,680
| -13% | -$2.84M | 0.31% | 103 |
|
|
2018
Q1 | $19.5M | Sell |
266,424
-20,612
| -7% | -$1.41M | 0.3% | 104 |
|
|
2017
Q4 | $16.7M | Sell |
287,036
-7,755
| -3% | -$408K | 0.24% | 128 |
|
|
2017
Q3 | $13.2M | Sell |
294,791
-4,806
| -2% | -$200K | 0.21% | 145 |
|
|
2017
Q2 | $11.8M | Sell |
299,597
-89,021
| -23% | -$3.66M | 0.19% | 154 |
|
|
2017
Q1 | $15.8M | Sell |
388,618
-48,203
| -11% | -$1.88M | 0.25% | 133 |
|
|
2016
Q4 | $17.6M | Sell |
436,821
-85,598
| -16% | -$3.23M | 0.28% | 135 |
|
|
2016
Q3 | $18.9M | Sell |
522,419
-2,578
| -0.5% | -$88.5K | 0.31% | 128 |
|
|
2016
Q2 | $15.2M | Sell |
524,997
-5,591
| -1% | -$169K | 0.26% | 141 |
|
|
2016
Q1 | $18.6M | Buy |
530,588
+1,719
| +0.3% | +$55.5K | 0.32% | 120 |
|
|
2015
Q4 | $17.1M | Sell |
528,869
-192,087
| -27% | -$6.23M | 0.32% | 131 |
|
|
2015
Q3 | $23.3M | Sell |
720,956
-30,310
| -4% | -$1.14M | 0.39% | 102 |
|
|
2015
Q2 | $31.1M | Sell |
751,266
-48,617
| -6% | -$2.05M | 0.47% | 84 |
|
|
2015
Q1 | $35.9M | Sell |
799,883
-46,022
| -5% | -$1.92M | 0.53% | 71 |
|
|
2014
Q4 | $31.7M | Sell |
845,905
-36,406
| -4% | -$1.33M | 0.47% | 92 |
|
|
2014
Q3 | $30.8M | Sell |
882,311
-21,555
| -2% | -$769K | 0.48% | 92 |
|
|
2014
Q2 | $31.9M | Buy |
903,866
+24,170
| +3% | +$807K | 0.46% | 103 |
|
|
2014
Q1 | $28.7M | Sell |
879,696
-6,457
| -0.7% | -$247K | 0.43% | 114 |
|
|
2013
Q4 | $37.3M | Buy |
886,153
+124,367
| +16% | +$5.12M | 0.54% | 75 |
|
|
2013
Q3 | $30.4M | Sell |
761,786
-12,227
| -2% | -$513K | 0.46% | 99 |
|
|
2013
Q2 | $32M | Buy |
+774,013
| New | +$31.3M | 0.52% | 85 |
|
Other funds holding HAE
AI
Boston Trust Walden's HAE Position: Q2 2026 in Review
Boston Trust Walden increased its Haemonetics (HAE) stake by 17% in Q2 2026, buying an estimated $5.35M and bringing the position to 585,148 shares worth $43.9M. The position accounts for 0.33% of the portfolio, ranked #106.
Boston Trust Walden first reported a position in HAE in Q2 2013 and has held it in 53 quarters since. The position peaked at $81.3M in Q2 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Boston Trust Walden held 585,148 shares of Haemonetics worth $43.9M as of Q2 2026.
- Boston Trust Walden bought 83,263 Haemonetics shares in Q2 2026, an estimated $5.35M.
- Haemonetics made up 0.33% of Boston Trust Walden's portfolio in Q2 2026, its #106 holding.
- Boston Trust Walden first reported a position in Haemonetics in Q2 2013 and has held it in 53 quarters since.
- Boston Trust Walden's Haemonetics position peaked at $81.3M in Q2 2025.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.